[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"brand-intercell-ag":3,"geo-intercell-ag":-1,"alternatives-intercell-ag":22},{"id":4,"slug":5,"name":6,"wikidata_qid":7,"gleif_lei":8,"isin":8,"ultimate_parent_id":8,"hq_country_code":9,"hq_city":10,"founded_year":11,"official_website":12,"manufacturing_countries":8,"logo_url":8,"description":13,"is_eu_headquartered":14,"is_eu_manufactured":14,"eu_score_label":15,"attributes":16,"data_quality":17,"enriched_at":18,"created_at":19,"updated_at":20,"ownership_type":8,"stock_exchange":8,"tax_domicile":8,"ultimate_parent_name":8,"ultimate_parent_country":8,"data_hosting_country":8,"cloud_act_exposure":8,"ai_training_on_user_data":8,"dsa_designation":8,"gdpr_fines_total_eur":8,"gdpr_compliance_status":8,"supply_chain_transparency":8,"sustainable_materials":8,"carbon_neutral":8,"repair_recycling_program":8,"pays_eu_taxes":8,"eu_regulatory_fines":8,"b_corp_certified":8,"ethical_certifications":8,"ownership_disclosed":8,"annual_report_published":8,"supply_chain_audit_published":8,"timeline_events":8,"extended_enriched_at":8,"category_primary_id":8,"category_secondary_id":8,"category_confidence":21},"ed120b01-84fa-46b2-8afa-2c1f049f48d6","intercell-ag","Intercell AG","Q874091",null,"AT","Vienna",1997,"http:\u002F\u002Fwww.intercell.com\u002F","Intercell AG was an Austrian biotechnology company focused on the development of novel vaccines for infectious diseases. In 2013, the company merged with Vivalis SA to form Valneva SE, which is currently headquartered in France.",true,"eu_all",{"gleif_searched":14},"complete","2026-07-19T15:16:38.951+00:00","2026-07-09T06:01:47.094323+00:00","2026-07-22T16:54:48.047757+00:00",0,[]]